PROGRAM
As we step into 2024, the global impact of prostate cancer continues to expand. Novel therapies for the treatment of advanced disease have seemed to multiply exponentially.
The conference will focus on the latest innovations in prostate cancer research, including the advancement of precision medicine and targeted therapies, the integration of artificial intelligence in the diagnostic algorithm and treatment pathways and the development of next generation imaging techniques. We will explore the potential of genomics in managing prostate cancer, as well as role of theranostics, treatment sequencing and treatment intensification.
Additionally, the conference will address aspects of patient quality of life and survivorship, underscoring the importance of holistic care in the journey of patient recovery.
Additionally, the conference will address aspects of patient quality of life and survivorship, underscoring the importance of holistic care in the journey of patient recovery.
The preliminary program will be released in April.
Supported By: